This article is over 5 years old

Bauer Business Focus

Houston Startup Tackles Dog Cancer

CAVU Biotherapies researches personalized cancer treatments for dogs and other pets



To embed this piece of audio in your site, please use this code:

<iframe src="" style="height: 115px; width: 100%;"></iframe>
Colleen O’Connor, who has a PhD in toxicology, founded CAVU after losing two dogs to cancer.

There's much talk about curing cancer — especially in Houston, the home of a prestigious cancer center.

But what about cancer in pets?

It is a niche the start-up CAVU Biotherapies, housed in the University of Houston's Innovation Center, wants to fill.

We spoke with CAVU founder Colleen O'Connor for this week's Bauer Business Focus.

Click on the play button above to listen to the interview.